What is Evidently?
Founded in 2020 by Feng Niu and Jaeho Shin, Evidently operates at the intersection of artificial intelligence and clinical operations. The company provides a sophisticated cognitive AI platform designed to function as an intelligent resident, automating labor-intensive tasks such as clinical summarization, research, and population health management. By integrating directly into existing clinical workflows, Evidently enables healthcare providers to maintain documentation integrity while significantly reducing the administrative burden on clinicians.
The platform's core value proposition lies in its ability to synthesize information from external health records and internal systems, providing actionable insights that support clinical decision-making. As healthcare organizations increasingly prioritize digital transformation, Evidently's technology serves as a critical infrastructure layer, facilitating better patient outcomes through data-driven automation and streamlined operational efficiency.
How much funding has Evidently raised?
Evidently has raised a total of $15M across 1 funding round:
Series A
$15M
Series A (2024): $15M with participation from DN Capital, Clear Ventures, and Fellows Fund
Key Investors in Evidently
DN Capital
A global early-stage venture capital firm with a focus on Software, AI, and Fintech, leveraging an extensive network to support high-growth technology companies.
Clear Ventures
An early-stage venture capital firm that provides seed capital and operational expertise to disruptive technology innovators, backed by a history of significant market exits.
Fellows Fund
A venture capital firm focused on AI and Web3.0, utilizing a brain trust of C-level experts and researchers to guide the commercialization of early-stage technologies.
What's next for Evidently?
With the successful closure of this latest capital round, Evidently is poised to expand its footprint across the healthcare provider landscape. The strategic focus will likely center on deepening the integration capabilities of its AI platform and scaling its deployment to support larger health systems. By leveraging the expertise of its investor base, the company is well-positioned to navigate the complexities of the healthcare technology market, focusing on product refinement and the commercialization of its documentation integrity solutions. As the firm continues to evolve, its ability to demonstrate measurable improvements in clinician productivity and patient care quality will be the primary metric for its long-term success in the competitive HealthTech sector.
See full Evidently company page
